Viking Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Viking Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Viking Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Viking Therapeutics by Barclays
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $7.8M | 124k | 63.32 |
2024-06-30 | $9.0M | 169k | 53.02 |
2024-03-31 | $16M | 196k | 81.99 |
2023-12-31 | $10M | 540k | 18.61 |
2023-09-30 | $5.8M | 522k | 11.07 |
2023-06-30 | $3.1M | 189k | 16.21 |
2023-03-31 | $3.0M | 181k | 16.65 |
2022-12-31 | $359k | 38k | 9.39 |
2022-09-30 | $11k | 4.0k | 2.73 |
2022-06-30 | $0 | 1 | 0.00 |
2022-03-31 | $35k | 11k | 3.06 |
2021-12-31 | $382k | 83k | 4.60 |
2021-09-30 | $180k | 29k | 6.31 |
2021-06-30 | $57k | 9.5k | 5.97 |
2021-03-31 | $517k | 82k | 6.32 |
2020-12-31 | $303k | 54k | 5.62 |
2020-09-30 | $430k | 74k | 5.81 |
2020-06-30 | $850k | 118k | 7.21 |
2020-03-31 | $359k | 77k | 4.67 |
2019-12-31 | $635k | 79k | 8.02 |
2019-09-30 | $234k | 34k | 6.88 |
2019-06-30 | $519k | 63k | 8.29 |
2019-03-31 | $172k | 17k | 9.96 |
2018-12-31 | $89k | 12k | 7.64 |
2018-09-30 | $7.4M | 427k | 17.44 |
2018-06-30 | $2.2M | 239k | 9.39 |
2018-03-31 | $64k | 15k | 4.39 |
2017-12-31 | $7.0k | 1.7k | 4.15 |